Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00717301 · ClinicalTrials.gov registry record
S-100B as Pre-Head CT Scan Screening Test After Mild Traumatic Brain Injury
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 1,252
- Enrollment target
NCT00717301 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 1,252 participants.
The verdict
NCT00717301 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 1,252 participants
- Enrollment target
Study Summary
The purpose of the study is to determine if a specific blood protein, S-100B, can help predict who will have a traumatic abnormality on head CT scan after a concussion. We will compare the levels of this protein in the subject's blood to the initial head CT scan and to how the subject is feeling one month after injury. We hope that the information we collect in this trial will help us determine who needs a head CT scan after a concussion and who may be more likely to have trouble recovering from a concussion.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,252 participants |
| Start Date | 2008-09 |
| Est. Completion | 2010-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00717301
The ClinicalTrials.gov registry entry for NCT00717301 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,252 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00717301 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00717301 about?
NCT00717301 is a clinical study titled "S-100B as Pre-Head CT Scan Screening Test After Mild Traumatic Brain Injury". The purpose of the study is to determine if a specific blood protein, S-100B, can help predict who will have a traumatic abnormality on head CT scan after a concussion. We will compare the levels of this protein in the subject's blood to the initial head CT scan and to how the subject is feeling one...
What is the current status of trial NCT00717301?
This trial is currently completed. The enrollment target is 1,252 participants. The study started on 2008-09. Estimated completion is 2010-09.
Who is sponsoring clinical trial NCT00717301?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.